Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive Motrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy
MOOV
1 other identifier
interventional
36
1 country
2
Brief Summary
One of the urgent priorities in the field of pediatric neuro-rehabilitation is the development of efficient early motor interventions for children with cerebral palsy (CP). Animal studies suggest that early intensive interventions are likely to have a significant impact on the organization of the brain and corticospinal tracts, reducing motor impairments and their medium and long-term consequences in children with cerebral palsy. Although most of the growth, development and cortical organization takes place in the time course of the first 2 years of life, most studies investigating the effectiveness of intensive rehabilitation and associated neurophysiological mechanisms have been conducted in school-aged children (\> 6 years). In addition, the vast majority of these studies were conducted in children with unilateral CP, while the bilateral form of the pathology has the highest prevalence. It is therefore a priority to investigate the effectiveness of early interventions on the overall motor function of children with CP, especially in children with bilateral form of CP. Hand and Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) makes it possible to apply the concepts of structured motor learning and intensive treatment to both the upper limbs and the lower limbs and demonstrated improvements at both levels in school-aged children with unilateral CP and bilateral and then at all three International Classification of Functioning and Disability levels. The principles and content of HABIT-ILE can be applied to pre-school children and this method is promising for early neuro-rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedStudy Start
First participant enrolled
January 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 17, 2021
CompletedMay 7, 2026
May 1, 2026
8 months
April 23, 2020
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gross Motor Function Measure (GMFM)
Measures change in gross motor function over time in children with cerebral palsy. The score range from 0 to 100 as a percentage. 100 is the best outcome.
1 hour
Secondary Outcomes (8)
Both Hands Assessment
up to 90 days
Melbourne Assessment 2
up to 90 days
ACTIVLIM-CP
up to 90 days
Young Children's Participation and Environment Measure
up to 90 days
Pediatric Evaluation of Disability Inventory Computer Adaptive Test
up to 90 days
- +3 more secondary outcomes
Study Arms (2)
Interventional
EXPERIMENTAL10 days of intensive and structured motor therapy, 5 hours a day = 50h
Control
PLACEBO COMPARATOR10 days of care and classic activities
Interventions
Electro-Encephalography-High Density (children with unilateral PC only) at baseline and J90
physiotherapy and psychomotility. As needed weekly sessions of speech therapist or orthoptist and daily activities of the child.
Eligibility Criteria
You may qualify if:
- Child with bilateral cerebral palsy proven to be spastic or dyskinetic
- to 4 years old inclusive (12 to 59 months) (age corrected if premature) able to follow instructions and to be able to carry out all the assessments, in accordance with his age
- Being matched to a child according to age, etiology of CP / classification of motor function (GMFCS)
- Signature of consent by the two holders of parental authority
You may not qualify if:
- Exceed 4 years and 11 months (59 months) during the internship evaluation period.
- Uncontrolled epilepsy.
- History of toxin injection or surgery in the 6 months preceding the study period or scheduled within 3 months (during the study period).
- Visual or cognitive deficit preventing the child from seeing the games and interacting
- Usual contraindications to magnetic resonance imaging (MRI) such as metal implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Les Capucins
Angers, Angers, 49000, France
Fondation ILDYS - Site de Ty Yann
Brest, Brest, 29000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2020
First Posted
April 27, 2020
Study Start
January 19, 2021
Primary Completion
September 17, 2021
Study Completion
September 17, 2021
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available after the publication of result and ending fifteen years following the last visit of the last patient
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication